Novel |
CHRNB4 |
cholinergic receptor nicotinic beta 4 subunit |
- Highly sodium permeable postsynaptic acetylcholine nicotinic receptors
- Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
- Highly calcium permeable nicotinic acetylcholine receptors
- Neutrophil degranulation
|
- Nicotine
- Succinylcholine
- Butabarbital
- Fluoxetine
- Dextromethorphan
- Cisatracurium
- Ethanol
- Pentolinium
- Levacetylmethadol
- Epibatidine
|
|
Novel |
GABRG2 |
gamma-aminobutyric acid type A receptor subunit gamma2 |
- Signaling by ERBB4
- GABA receptor activation
- GABA receptor activation
|
- Lorazepam
- Lorazepam
- Ethchlorvynol
- Enflurane
- Temazepam
- Temazepam
- Butabarbital
- Butalbital
- Phenytoin
- Etomidate
- Talbutal
- Pentobarbital
- Olanzapine
- Clobazam
- Clobazam
- Meprobamate
- Carisoprodol
- Eszopiclone
- Alprazolam
- Alprazolam
- Zolpidem
- Metharbital
- Chlordiazepoxide
- Chlordiazepoxide
- Amoxapine
- Adinazolam
- Adinazolam
- Lamotrigine
- Lamotrigine
- Medroxyprogesterone acetate
- Clorazepic acid
- Clorazepic acid
- Midazolam
- Midazolam
- Flurazepam
- Flurazepam
- Isoflurane
- Primidone
- Halazepam
- Halazepam
- Propofol
- Diazepam
- Diazepam
- Oxazepam
- Oxazepam
- Triazolam
- Triazolam
- Zonisamide
- Methoxyflurane
- Memantine
- Clonazepam
- Clonazepam
- Methyprylon
- Halothane
- Desflurane
- Flumazenil
- Flumazenil
- Estazolam
- Estazolam
- Sevoflurane
- Ginkgo biloba
- Glutethimide
- Camazepam
- Camazepam
- Delorazepam
- Delorazepam
- Flunitrazepam
- Flunitrazepam
- Ethyl loflazepate
- Ethyl loflazepate
- Cloxazolam
- Cloxazolam
- Bromazepam
- Bromazepam
- Clotiazepam
- Clotiazepam
- Fludiazepam
- Ketazolam
- Ketazolam
- Prazepam
- Prazepam
- Quazepam
- Quazepam
- Cinolazepam
- Cinolazepam
- Nitrazepam
- Nitrazepam
- Prasterone
- Taurine
- Ganaxolone
- Adipiplon
- Brotizolam
- Brotizolam
- Stiripentol
- Etizolam
- Etizolam
- Thiocolchicoside
- Brexanolone
- Apalutamide
- Remimazolam
- Remimazolam
- Muscimol
- 1,2-Benzodiazepine
- 1,2-Benzodiazepine
- Pinazepam
- Pinazepam
- Medazepam
- Medazepam
- Loprazolam
- Loprazolam
- Doxefazepam
- Doxefazepam
- Lormetazepam
- Lormetazepam
- 5,7,2′-trihydroxy-6,8-dimethoxyflavone
- Nordazepam
- Nordazepam
- Oxazepam acetate
- Oxazepam acetate
- Cinazepam
- Cinazepam
- Bentazepam
- Bentazepam
- Mexazolam
- Mexazolam
|
- Febrile seizures, including: Febrile convulsions; Generalized epilepsy with febrile seizure plus (GEFS+); Dravet syndrome/ Severe myoclonic epilepsy in infancy (SMEI)
- Idiopathic generalied epilepsies (IGEs), including: Childhood absence epilepsy (CAE); Juvenile absence epilepsy (JAE); Juvenile myoclonic epilepsy (JME); Epilepsy with generalized tonic-clonic seizures alone
|
Novel |
GAR1 |
GAR1 ribonucleoprotein |
- Telomere Extension By Telomerase
- rRNA modification in the nucleus and cytosol
|
|
|
Novel |
MCUB |
mitochondrial calcium uniporter dominant negative subunit beta |
- Mitochondrial calcium ion transport
- Processing of SMDT1
|
|
|
Novel |
OSTC |
oligosaccharyltransferase complex non-catalytic subunit |
- Asparagine N-linked glycosylation
- Maturation of spike protein
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
- PD-L1(CD274) glycosylation and translocation to plasma membrane
|
|
|
Novel |
PAPSS1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
- Transport and metabolism of PAPS
- Metabolism of ingested H2SeO4 and H2SeO3 into H2Se
- Signaling by BRAF and RAF1 fusions
|
- Adenosine-5'-diphosphate-2',3'-vanadate
- Adenosine 5'-phosphosulfate
- Glycerin
|
|
Novel |
PPA2 |
inorganic pyrophosphatase 2 |
- Mitochondrial tRNA aminoacylation
- Pyrophosphate hydrolysis
|
|
|
Novel |
PUF60 |
poly(U) binding splicing factor 60 |
- mRNA Splicing - Major Pathway
|
|
|
Novel |
RRH |
retinal pigment epithelium-derived rhodopsin homolog |
- G alpha (i) signalling events
- Opsins
|
|
|
Novel |
SMS |
spermine synthase |
|
|
|
Novel |
ZGRF1 |
zinc finger GRF-type containing 1 |
|
|
|
|
APP |
amyloid beta precursor protein |
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1-dependent IKK and NF-kappa-B activation
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Tromethamine
- Phenserine
- Tetrathiomolybdate
- CAD106
- Mito-4509
- Edonerpic
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
- Gantenerumab
- Aducanumab
- Zinc acetate
- Aluminium phosphate
- Aluminum acetate
- Zinc chloride
- Zinc sulfate, unspecified form
- Lecanemab
|
|
|
BARD1 |
BRCA1 associated RING domain 1 |
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HRR)
- UCH proteinases
- Metalloprotease DUBs
- Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Resolution of D-loop Structures through Holliday Junction Intermediates
- Nonhomologous End-Joining (NHEJ)
- Homologous DNA Pairing and Strand Exchange
- Processing of DNA double-strand break ends
- Presynaptic phase of homologous DNA pairing and strand exchange
- Regulation of TP53 Activity through Phosphorylation
- G2/M DNA damage checkpoint
- Defective DNA double strand break response due to BRCA1 loss of function
- Defective DNA double strand break response due to BARD1 loss of function
- Defective homologous recombination repair (HRR) due to BRCA1 loss of function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
- Impaired BRCA2 binding to RAD51
- Impaired BRCA2 binding to PALB2
|
|
|
|
BRCA1 |
BRCA1 DNA repair associated |
- Meiotic synapsis
- SUMOylation of DNA damage response and repair proteins
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HRR)
- Metalloprotease DUBs
- Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Resolution of D-loop Structures through Holliday Junction Intermediates
- Nonhomologous End-Joining (NHEJ)
- Homologous DNA Pairing and Strand Exchange
- Processing of DNA double-strand break ends
- Presynaptic phase of homologous DNA pairing and strand exchange
- TP53 Regulates Transcription of DNA Repair Genes
- Regulation of TP53 Activity through Phosphorylation
- G2/M DNA damage checkpoint
- Neddylation
- Transcriptional Regulation by E2F6
- Meiotic recombination
- Defective DNA double strand break response due to BRCA1 loss of function
- Defective DNA double strand break response due to BARD1 loss of function
- Defective homologous recombination repair (HRR) due to BRCA1 loss of function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
- Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
- Impaired BRCA2 binding to RAD51
- Impaired BRCA2 binding to PALB2
- KEAP1-NFE2L2 pathway
- Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence
|
|
- Ovarian cancer
- Breast cancer
|
|
JMJD6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
- HDMs demethylate histones
- Protein hydroxylation
|
|
|
|
LRRK2 |
leucine rich repeat kinase 2 |
- PTK6 promotes HIF1A stabilization
|
|
- Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
- Parkinson's disease (PD)
|
|
MIR1-1 |
microRNA 1-1 |
|
|
|
|
MIR1-2 |
microRNA 1-2 |
|
|
|
|
MIR106A |
microRNA 106a |
|
|
|
|
MIR106B |
microRNA 106b |
|
|
|